Control group:Conventional fractionated intensity-modulated radiotherapy

2 trials

Sponsors

Chinese Academy of Medical Sciences & Peking Union Medical College, Fifth Affiliated Hospital, Sun Yat-Sen University

Conditions

Patients with locally advanced nasopharyngeal carcinoma who did not respond (assessed as SD/PD by imaging) to immunotherapy combined with platinum-based chemotherapyPostoperative cervical or uterine corpus cancer

Phase 2

Gradient Hyperfractionation Compared With Conventional Fractionation Combined With Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma That Has Not Achieved Remission After Neoadjuvant Chemoimmunotherapy: a Phase II Clinical Trial

Active, not recruitingChiCTR2500115847

Fifth Affiliated Hospital, Sun Yat-Sen UniversityPatients with locally advanced nasopharyngeal carcinoma who did not respond (assessed as SD/PD by imaging) to immunotherapy combined with platinum-based chemotherapy

Start: 2025-12-31Updated: 2026-01-05

Phase 3

A Multicenter, Non-Inferiority, Phase III Randomized Controlled Trial Comparing Moderately Hypofractionated Online Adaptive Radiotherapy(MH-ART) vs. Conventional Fractionated Intensity-Modulated Radiotherapy(CF-IMRT) in Postoperative Cervical Cancer and Endometrial Cancer

Active, not recruitingChiCTR2500108984

Chinese Academy of Medical Sciences & Peking Union Medical CollegePostoperative cervical or uterine corpus cancer

Start: 2025-09-30Updated: 2025-09-15